GLP-1 Safety Concerns

Monitoring continues for gastrointestinal effects, dehydration, inadequate nutrition, reduced movement, hair loss, body-contour changes, and possible bone, tendon, nutrient, kidney, and visual concerns. Retatrutide remains investigational and grey-market sourcing is unsafe; regain after interruption and possible cardiovascular risk after cessation strengthen the case for continuity, nutrition, resistance training, and clinical monitoring. Today's app and exercise coverage added no safety evidence.